DCM
COGT icon

Driehaus Capital Management’s Cogent Biosciences COGT Stock Holding History

Driehaus Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-565,484
Closed -$4.96M – 450
2021
Q1 		$4.96M Sell
565,484
-78,584
-12% -$757K 0.07% 277
2020
Q4 		$7.23M Buy
644,068
+594,068
+1,188% +$6.53M 0.12% 208
2020
Q3 		$468K Buy
+50,000
New +$521K 0.01% 338

Other funds holding COGT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Driehaus Capital Management's COGT Position: Q2 2021 in Review

Driehaus Capital Management sold out of Cogent Biosciences (COGT) in Q2 2021, closing a stake of 565,484 shares — an estimated $4.96M sold.

Driehaus Capital Management first reported a position in COGT in Q3 2020 and held it in 3 quarters. The position peaked at $7.23M in Q4 2020. 69 funds tracked by Wall St. Rank hold COGT as of Q2 2021.

  • Driehaus Capital Management reported no remaining Cogent Biosciences position as of Q2 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 565,484 Cogent Biosciences shares in Q2 2021, an estimated $4.96M.
  • Driehaus Capital Management first reported a position in Cogent Biosciences in Q3 2020 and held it in 3 quarters.
  • Driehaus Capital Management's Cogent Biosciences position peaked at $7.23M in Q4 2020.
  • 69 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2021.

Based on Driehaus Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.